Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Corium International Inc (CORI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3472
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products include Corplex Memantine and Corplex Donepezil for the treatment of Alzheimer’s disease. Corium also develops MicroCor PTH for the treatment of osteoporosis using another technology platform called MicroCor system. The company provides proprietary development programs, contract research and development services. It partners with pharmaceutical and consumer products companies. The company operates through its research and development facility in Grand Rapids, the US. Corium is headquartered in Menlo Park, California, the US.

Corium International Inc (CORI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corium International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Corium International Inc, Medical Devices Deals, 2012 to YTD 2018 9
Corium International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Corium International Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Aequus Pharma Enters into Co-Development Agreement with Corium International 11
Aequus Pharma Enters into Co-Development Agreement with Corium International 12
Equity Offering 13
Corium Plans to Raise USD150 Million in Public Offering of Securities 13
Corium International Raises USD40.3 Million in Public Offering of Shares 14
Corium International Raises USD20 Million in Public Offering of Shares 16
Corium International Raises USD52 Million in Public Offering of Shares 17
Debt Offering 19
Corium International Prices Private Placement of Notes Due 2025 for USD100 Million 19
Corium International Inc – Key Competitors 20
Corium International Inc – Key Employees 21
Corium International Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 09, 2018: Corium International announces third quarter fiscal 2018 financial results 23
May 14, 2018: Corium Announces Second Quarter Fiscal 2018 Financial Results 25
Feb 08, 2018: Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights 26
Nov 16, 2017: Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights 27
Aug 03, 2017: Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017 29
May 11, 2017: Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights 30
Feb 13, 2017: Corium Reports First Quarter Fiscal 2017 Financial Results 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Corium International Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corium International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corium International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Corium International Inc, Medical Devices Deals, 2012 to YTD 2018 9
Corium International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aequus Pharma Enters into Co-Development Agreement with Corium International 11
Aequus Pharma Enters into Co-Development Agreement with Corium International 12
Corium Plans to Raise USD150 Million in Public Offering of Securities 13
Corium International Raises USD40.3 Million in Public Offering of Shares 14
Corium International Raises USD20 Million in Public Offering of Shares 16
Corium International Raises USD52 Million in Public Offering of Shares 17
Corium International Prices Private Placement of Notes Due 2025 for USD100 Million 19
Corium International Inc, Key Competitors 20
Corium International Inc, Key Employees 21
Corium International Inc, Other Locations 22

List of Figures
Corium International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corium International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Corium International Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Uscom Ltd. (UCM):医療機器:M&Aディール及び事業提携情報
    Summary Uscom Ltd. (Uscom) is a medical device company that operates in non-invasive hemodynamic market. It focuses on the development, design, manufacture and marketing of non-invasive cardiac monitoring devices. Uscom’s product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac o …
  • Croatia Airlines d.d.:企業の戦略・SWOT・財務情報
    Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • BNP Paribas Cardif:企業の戦略・SWOT・財務情報
    BNP Paribas Cardif - Strategy, SWOT and Corporate Finance Report Summary BNP Paribas Cardif - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Midland Power Cooperative:企業の戦略的SWOT分析
    Midland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Penta-Ocean Construction Co Ltd:戦略・SWOT・企業財務分析
    Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ALLETE Inc (ALE):企業の財務・戦略的SWOT分析
    ALLETE Inc (ALE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Westwater Resources, Inc.:企業のM&A・事業提携・投資動向
    Westwater Resources, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westwater Resources, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-euphoric cannabinoid, formulate …
  • Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs. The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma. …
  • Nexter Group:企業の戦略・SWOT・財務情報
    Nexter Group - Strategy, SWOT and Corporate Finance Report Summary Nexter Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • FTS International Services LLC:企業の戦略的SWOT分析
    FTS International Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Mahanagar Telephone Nigam Ltd (MTNL):企業の財務・戦略的SWOT分析
    Mahanagar Telephone Nigam Ltd (MTNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Gunma Bank Ltd
    The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CropEnergies AG (CE2):企業の財務・戦略的SWOT分析
    CropEnergies AG (CE2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CMS Energy Corp:企業の発電所・SWOT分析2018
    CMS Energy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Groupama Assurances Mutuelles:企業の戦略的SWOT分析
    Groupama Assurances Mutuelles - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Dialog Group Bhd (DIALOG):企業の財務・戦略的SWOT分析
    Dialog Group Bhd (DIALOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Vaxart Inc (AVIR):企業の財務・戦略的SWOT分析
    Vaxart Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務分析
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Europa Oil & Gas (Holdings) plc (EOG):企業の財務・戦略的SWOT分析
    Summary Europa Oil & Gas (Holdings) Plc (Europa Oil) is an oil and gas company that offers exploration and development services. The company's services include production and development of conventional and unconventional hydrocarbon assets. It operates its assets in East Midlands basin, Aquitain ba …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆